TITLE

Stressed liver and muscle call on adipocytes with FGF21

AUTHOR(S)
Yongde Luo; McKeehan, Wallace L.
PUB. DATE
December 2013
SOURCE
Frontiers in Endocrinology;Dec2013, Vol. 4, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Fibroblast growth factor 21 (FGF21) is an emerging regulator of local and systemic metabolic homeostasis. Treatment with pharmacological levels of FGF21 alleviates obesity and associated metabolic diseases including diabetes. However, beyond anti-obesogenic effects, the normal roles and underlying mechanisms of FGF21 as an endocrine hormone remain unclear. A recent wave of studies has revealed that FGF21 is a stress-induced endocrine factor in liver, muscle, and other tissues that targets adipose tissue and adipocytes through the FGFR1-betaKlotho complex. Adipose tissues and adipocytes within diverse tissues respond with metabolites and adipokine signals that affect functions of body tissues systemically and cells within the local microenvironment adjacent to adipocytes. Normally this is to prevent impaired tissue-specific function and damage to diverse tissues secreting FGF21 in response to chronic stress. Therefore, diverse stressed tissues and the adipose tissue and adipocytes constitute a beneficial endocrine and paracrine communication network through FGF21. Here we attempt to unify these developments with beneficial pharmacological effects of FGF21 on obesity in respect to inter-organ stress communication and mechanisms.
ACCESSION #
95829158

 

Related Articles

  • Evidence against a Beneficial Effect of Irisin in Humans. Raschke, Silja; Elsen, Manuela; Gassenhuber, Hans; Sommerfeld, Mark; Schwahn, Uwe; Brockmann, Barbara; Jung, Raphael; Wisløff, Ulrik; Tjønna, Arnt E.; Raastad, Truls; Hallén, Jostein; Norheim, Frode; Drevon, Christian A.; Romacho, Tania; Eckardt, Kristin; Eckel, Juergen // PLoS ONE;Sep2013, Vol. 8 Issue 9, p1 

    Brown adipose tissue has gained interest as a potential target to treat obesity and metabolic diseases. Irisin is a newly identified hormone secreted from skeletal muscle enhancing browning of white fat cells, which improves systemic metabolism by increasing energy expenditure in mice. The...

  • Fibroblast Growth Factor 1. Hutley, Louise; Shurety, Wenda; Newell, Felicity; McGeary, Ross; Pelton, Nicole; Grant, Jennifer; Herington, Adrian; Cameron, Donald; Whitehead, Jon; Prins, Johannes // Diabetes;Dec2004, Vol. 53 Issue 12, p3097 

    Obesity, with its related problems, is recognized as the fastest growing disease epidemic facing the world, yet we still have limited insight into the regulation of adipose tissue mass in humans. We have previously shown that adipose-derived microvascular endothelial cells (MVECs) secrete a...

  • A PPAR?-FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis. Jonker, Johan W.; Suh, Jae Myoung; Atkins, Annette R.; Ahmadian, Maryam; Li, Pingping; Whyte, Jamie; He, Mingxiao; Juguilon, Henry; Yin, Yun-Qiang; Phillips, Colin T.; Yu, Ruth T.; Olefsky, Jerrold M.; Henry, Robert R.; Downes, Michael; Evans, Ronald M. // Nature;5/17/2012, Vol. 485 Issue 7398, p391 

    Although feast and famine cycles illustrate that remodelling of adipose tissue in response to fluctuations in nutrient availability is essential for maintaining metabolic homeostasis, the underlying mechanisms remain poorly understood. Here we identify fibroblast growth factor 1 (FGF1) as a...

  • Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases. Cao, Yihai // Nature Reviews Drug Discovery;Feb2010, Vol. 9 Issue 2, p107 

    Current pharmacotherapeutic options for treating obesity and related metabolic disorders remain limited and ineffective. Emerging evidence shows that modulators of angiogenesis affect the expansion and metabolism of fat mass by regulating the growth and remodelling of the adipose tissue...

  • Fibroblast Growth Factor 21 Improves Insulin Sensitivity and Synergizes with Insulin in Human Adipose Stem Cell-Derived (hASC) Adipocytes. Lee, Darwin V.; Li, Dongmei; Yan, Qingyun; Zhu, Yimin; Goodwin, Bryan; Calle, Roberto; Brenner, Martin B.; Talukdar, Saswata // PLoS ONE;Nov2014, Vol. 9 Issue 11, p1 

    Fibroblast growth factor 21 (FGF21) has evolved as a major metabolic regulator, the pharmacological administration of which causes weight loss, insulin sensitivity and glucose control in rodents and humans. To understand the molecular mechanisms by which FGF21 exerts its metabolic effects, we...

  • FGF21 as a Stress Hormone: The Roles of FGF21 in Stress Adaptation and the Treatment of Metabolic Diseases. Kook Hwan Kim; Myung-Shik Lee // Diabetes & Metabolism Journal;Aug2014, Vol. 38 Issue 4, p245 

    Fibroblast growth factor 21 (FGF21) is an endocrine hormone that is primarily expressed in the liver and exerts beneficial effects on obesity and related metabolic diseases. In addition to its remarkable pharmacologic actions, the physiological roles of FGF21 include the maintenance of energy...

  • CCAAT/enhancer binding protein and nuclear factor-Y regulate adiponectin gene expression in adipose tissue. Park, Sang-kyu; Oh, So-Young; Lee, Min-Young; Yoon, Sarah; Kim, Kyung-Sup; Kim, Jae-woo // Diabetes;Nov2004, Vol. 53 Issue 11, p2757 

    Adiponectin is one of the adipokines secreted by adipocytes and regulates energy homeostasis associated with insulin sensitivity, suggesting a possibility of nutritional regulation of adiponectin gene expression. In this study, we showed that the transcription of adiponectin gene was induced 4-6...

  • Metabolic disorders: FGF21 action in the fat. Levinson, Randy // Nature Medicine;Mar2012, Vol. 18 Issue 3, p360 

    The article focuses on the study which investigates the antiobesity and antidiabetic effects of fibroblast growth factor 21 (FGF21).

  • The PPARγ-FGF1 axis: an unexpected mediator of adipose tissue homeostasis. Sun, Kai; Scherer, Philipp E // Cell Research;Oct2012, Vol. 22 Issue 10, p1416 

    Adipose tissue remodeling is a dynamic process during nutritional fluctuation that plays critical roles in metabolic homeostasis and insulin sensitivity. The process is highly regulated by many factors, including adipokines and cytokines that are locally released within fat pads. In a recent...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics